1975Leprosy ReviewOpen access

Treatment of Leprosy with Clofazimine, Rifampicin and Bayrena

J. LANGUILLON

Open full text 5 citations

Abstract

In Africa, 8% of leprosy patients have the lepromatous form, and 85% have the tuberculoid form of the disease.Treating these patients with dapsone needs severa] years to produce good results, treatment with acedapsone is still in the experimental st age, and rifampicin is too expensive.There are two drugs remaining; clofazimine, which is the treatment of choice for those with lepromatous leprosy, and sulphanilamides, treatment for the tuberculoid form of leprosy and for acute inflammation af the peripheral nerves.

Open-access reader

About this research paper

What this paper is about

In Africa, 8% of leprosy patients have the lepromatous form, and 85% have the tuberculoid form of the disease.Treating these patients with dapsone needs severa] years to produce good results, treatment with acedapsone is still in the experimental st age, and rifampicin is too expensive.There are two drugs remaining; clofazimine, which is the treatment of choice for those with lepromatous leprosy, and sulphanilamides, treatment for the tuberculoid form of leprosy and for acute inflammation af the peripheral nerves.

Why it matters

OpenAlex reports 5 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

In Africa, 8% of leprosy patients have the lepromatous form, and 85% have the tuberculoid form of the disease.Treating these patients with dapsone needs severa] years to produce good results, treatment with acedapsone is still in the experimental st age, and rifampicin is too expensive.There are two drugs remaining; clofazimine, which is the treatment of choice for those with lepromatous leprosy, and sulphanilamides, treatment for the tuberculoid form of leprosy and for acute inflammation af the peripheral nerves.

Key concepts: Clofazimine, Rifampicin, Leprosy, Medicine, Tuberculosis, Dapsone, Dermatology, Pathology

Related papers

Back to paper searchBrowse research topicsOriginal source
Treatment of Leprosy with Clofazimine, Rifampicin and Bayrena — Research Paper | ScholarLens